Synapse

← Eric D. Peterson

Papers by Eric D. Peterson

Page 3 · newest first

  1. Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community PracticeJAMA Cardiology · 2022
  2. Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United StatesCirculation · 2022
  3. Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMISJournal of the American Heart Association · 2022
  4. Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationHeart Rhythm O2 · 2022
  5. The Texas Health Resources Clinical Scholars Program: Learning healthcare system workforce development through embedded translational researchLearning Health Systems · 2022
  6. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular diseaseCardiovascular Diabetology · 2022
  7. Using EHR data to identify coronavirus infections in hospitalized patients: Impact of case definitions on disease surveillanceInternational Journal of Medical Informatics · 2022
  8. Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic StrokeJAMA Network Open · 2022
  9. Automated analysis of limited echocardiograms: Feasibility and relationship to outcomes in COVID-19Frontiers in Cardiovascular Medicine · 2022
  10. Validation of the WATCH‐DM and TRS‐HF DM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort AnalysisJournal of the American Heart Association · 2022
  11. Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic StrokeJAMA Internal Medicine · 2022
  12. Association of Recent Use of Non–Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With AlteplaseJAMA · 2022
  13. Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement InterventionStroke · 2021
  14. Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemiaEuropean Journal of Heart Failure · 2021
  15. Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision MedicineDiabetes Care · 2021
  16. The importance of weight stabilization amongst those with overweight or obesity: Results from a large health care systemPreventive Medicine Reports · 2021
  17. Association Between Patient Survival and Clinician Variability in Treatment Rates for Aortic Valve StenosisJournal of the American Heart Association · 2021
  18. Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsJAMA Network Open · 2021
  19. The Cumulative Impact of Chronic Stressors on Risks of Myocardial Infarction in US Older AdultsPsychosomatic Medicine · 2021
  20. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2021
  21. Sex disparities in patients with symptomatic severe aortic stenosisAmerican Heart Journal · 2021
  22. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral HemorrhageJAMA Network Open · 2021
  23. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention TherapyCirculation Cardiovascular Quality and Outcomes · 2021
  24. Perceived Versus Actual Risks of 30-Day Readmission in Patients With Cardiovascular DiseaseCirculation Cardiovascular Quality and Outcomes · 2021
  25. Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 scoreStroke and Vascular Neurology · 2020
  26. Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan PolicyJAMA Internal Medicine · 2020
  27. Prevalence, treatment, and control of severe hyperlipidemiaAmerican Journal of Preventive Cardiology · 2020
  28. Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement EraJournal of the American Heart Association · 2020
  29. Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering TherapiesJournal of the American Heart Association · 2020
  30. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)The American Journal of Cardiology · 2020
  31. Patterns of oral anticoagulation use with cardioversion in clinical practiceHeart · 2020
  32. Rationale and design of “Hearts & Parks”: study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesityBMC Pediatrics · 2020
  33. China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trialAmerican Heart Journal · 2020
  34. Effect of intervention timing on one-year mortality in elderly non–ST-segment elevation myocardial infarction patientsCoronary Artery Disease · 2020
  35. The Project Baseline Health Study: a step towards a broader mission to map human healthnpj Digital Medicine · 2020
  36. Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registriesEP Europace · 2020
  37. The association between triglycerides and incident cardiovascular disease: What is “optimal”?Journal of clinical lipidology · 2020
  38. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisionsEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2020
  39. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in PracticeCirculation Cardiovascular Interventions · 2020
  40. Time to benefit and harm of intensive blood pressure treatment: insights from SPRINTEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2020
  41. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJournal of the American Heart Association · 2020
  42. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial FibrillationCirculation Arrhythmia and Electrophysiology · 2020
  43. Association Between Intensive Care Unit Usage and Long‐Term Medication Adherence, Mortality, and Readmission Among Initially Stable Patients With Non–ST‐Segment–Elevation Myocardial InfarctionJournal of the American Heart Association · 2020
  44. Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy FillJAMA Cardiology · 2020
  45. Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle AgeJAMA Cardiology · 2020
  46. Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney diseaseAmerican Heart Journal · 2020
  47. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillationHeart · 2020
  48. Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2020
  49. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 MonthsCirculation Cardiovascular Quality and Outcomes · 2020
  50. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart FailureJournal of the American Heart Association · 2019